NKGen Biotech, Inc. Warrants
Financial ratios & Valuation

Historical Multiples (2021 – 2023)

2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.26-1.35-0.51N/A-1.35
Price/Sales ratio
287.53471.36N/AN/A471.36
Price/Book Value ratio
-3.2123.22-0.72N/A23.22
Price/Cash Flow ratio
-6.26-1.60-1.93N/A-1.60
Price/Free Cash Flow ratio
-6.12-1.59-1.92N/A-1.59
Price/Earnings Growth ratio
N/A-0.00-0.01N/A-0.00
Dividend Yield
N/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
92.95%76.62%N/AN/A76.62%
Operating Profit Margin
-5131.69%-31618.18%N/AN/A-31618.18%
Pretax Profit Margin
-5460.09%-34736.36%N/AN/A-34736.36%
Net Profit Margin
-5461.26%-34745.45%N/AN/A-34745.45%
Effective Tax Rate
-0.02%-0.02%-0.00%N/A-0.02%
Return on Assets
-128.74%-163.83%-503.33%N/A-163.83%
Return On Equity
61.14%-1711.70%141.33%N/A-1711.70%
Return on Capital Employed
58.02%-1532.15%129.49%N/A-1532.15%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A
Quick Ratio
0.000.010.04N/A0.01
Cash ratio
0.000.000.00N/A0.00
Days of Sales Outstanding
57.40455.06N/AN/A455.06
Days of Inventory outstanding
2.09K2.69KN/AN/A2.69K
Operating Cycle
2.15K3.15KN/AN/A3.15K
Days of Payables Outstanding
20.85K19.77K3.34KN/A19.77K
Cash Conversion Cycle
-18.70K-16.61KN/AN/A-16.61K
Debt Ratios
Debt Ratio
2.830.711.20N/A0.71
Debt Equity Ratio
-1.347.45-0.33N/A7.45
Long-term Debt to Capitalization
N/AN/A-0.20N/AN/A
Total Debt to Capitalization
3.900.88-0.51N/A0.88
Interest Coverage Ratio
N/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-0.38-1.93-1.10N/A-1.93
Company Equity Multiplier
-0.4710.44-0.28N/A10.44
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-45.88-292.94N/AN/A-292.94
Free Cash Flow / Operating Cash Flow Ratio
1.021.001.00N/A1.00
Cash Flow Coverage Ratio
-0.38-1.93-1.10N/A-1.93
Short Term Coverage Ratio
-0.38-1.93-2.19N/A-1.93
Dividend Payout Ratio
N/AN/AN/AN/AN/A